Tech Company Financing Transactions
Imara Funding Round
Imara closed a $31 million Series A funding round on 4/15/2016. Investors included Alexandria Venture Investments, Bay City Capital and Lundbeckfond Ventures.
Transaction Overview
Company Name
Announced On
4/15/2016
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series A
Investors
Proceeds Purpose
The funds will allow Imara to develop IMR-687, a disease-modifying therapeutic discovered by H. Lundbeck A/S and selected specifically for the treatment of sickle cell disease and other hemoglobinopathies. Lundbeck granted Imara an exclusive worldwide license and will receive certain milestone payments and royalties on sales as well as minority ownership in Imara.
Company Information
Company Status
Publicly-held
Industry
Energy & Battery
Mailing Address
700 Technology Sq. 3rd Floor
Cambridge, CA 02139
USA
Cambridge, CA 02139
USA
Phone
Email Address
Not Recorded
Overview
Imara Corporation's (formerly Lion Cells) mission is to provide superior energy storage solutions and accelerate the adoption of alternative U.S.- based green energy sources.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rahul Ballal
Browse more venture capital transactions:
Prev: 4/15/2016: Covalent Data venture capital transaction
Next: 4/15/2016: Innara Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs